Long-Term Efficacy (up to 68 Weeks) of Baricitinib in Combination with Topical Corticosteroids in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Analysis of Treatment Responders, Partial Responders and Nonresponders Originating from Study BREEZE-AD7.
Jonathan Ian SilverbergEric L SimpsonJacob Pontoppidan ThyssenT WerfelT CardilloS ColvinE PierceY ChenS ChenL EichenfieldPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Baricitinib 4-mg and 2-mg combined with TCS maintained clinically meaningful sustained efficacy over 68 weeks of continuous treatment.